Model reveals strategies to modify the tumor microenvironment and improve cancer therapy
Researchers from Mass General Brigham and the University of Cyprus have developed a mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC). The work is published in the Journal for ImmunoTherapy of Cancer.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Dark kitchens are popping up everywhere, but what are they and why does it matter?
Australia
-
Owning a smartphone at 12 linked to eating disorder symptoms
United Kingdom
-
Kidney disease in Nicaragua linked to adolescents and young women, and those without occupational heat exposure
United Kingdom
-
Coastal Golf Course Turned into Vital Wetland Habitat for Seabirds
United Kingdom
-
I stopped reading bad news for 48 hours. Here’s what happened
United Kingdom
-
Streamlining CRISPR workflows, from editing to analysis
United Kingdom
-
First Ever Recorded Sea Turtle Nests on America’s West Coast
United Kingdom
-
A startup wants to build a massive nuclear-powered data center on public land in Utah
United States